Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Results of Operations
PODD logo

Insulet Revenues Surge 34% as Omnipod 5 Dominates Global Diabetes Market

PODD10-QFiling Date: 5/6/2026
Insulet Corporation
Description

What this story covers

Insulet Corporation reported a 33.9% revenue increase to $761.7 million in Q1 2026, driven by global Omnipod 5 adoption. Despite a $30 million product correction, net income doubled, supported by strong international expansion and strategic share repurchases.

Story snapshot

CompanyInsulet Corporation
TickerPODD
VariantStandard detailed
Duration11:16
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001145197-26-000102
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in